$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022014502 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$16.12M	$15.47M
YoY Change	4.21%	-2.42%
Cost Of Revenue	$16.91M	$15.07M
YoY Change	12.19%	2.22%
Gross Profit	-$786.0K	$401.0K
YoY Change	-296.01%	-63.97%
Gross Profit Margin	-4.87%	2.59%
Selling, General & Admin	$4.273M	$5.774M
YoY Change	-26.0%	-21.4%
% of Gross Profit		1439.9%
Research & Development	$1.567M	$1.809M
YoY Change	-13.38%	-0.71%
% of Gross Profit		451.12%
Depreciation & Amortization	$138.0K	$202.0K
YoY Change	-31.68%	-3.35%
% of Gross Profit		50.37%
Operating Expenses	$5.840M	$7.583M
YoY Change	-22.99%	-17.29%
Operating Profit	-$6.626M	-$7.182M
YoY Change	-7.74%	-10.84%
Interest Expense	$540.0K	$581.0K
YoY Change	-7.06%	469.61%
% of Operating Profit
Other Income/Expense, Net	-$536.0K	-$570.0K
YoY Change	-5.96%	-902.82%
Pretax Income	-$7.162M	-$7.752M
YoY Change	-7.61%	-2.86%
Income Tax
% Of Pretax Income
Net Earnings	-$7.162M	-$7.752M
YoY Change	-7.61%	-2.91%
Net Earnings / Revenue	-44.42%	-50.1%
Basic Earnings Per Share	-$0.84	-$0.91
Diluted Earnings Per Share	-$0.84	-$0.91
COMMON SHARES
Basic Shares Outstanding	8.544M shares	8.508M shares
Diluted Shares Outstanding	8.544M shares	8.508M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.900M	$46.14M
YoY Change	-78.54%	-5.65%
Cash & Equivalents	$9.900M	$35.68M
Short-Term Investments	$0.00	$10.46M
Other Short-Term Assets	$2.231M	$2.389M
YoY Change	-6.61%	35.74%
Inventory	$5.531M	$4.117M
Prepaid Expenses
Receivables	$7.121M	$6.597M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$24.80M	$59.24M
YoY Change	-58.14%	-0.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.377M	$2.472M
YoY Change	-3.84%	1.72%
Goodwill	$921.0K	$921.0K
YoY Change	0.0%	0.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$618.0K	$629.0K
YoY Change	-1.75%	12.2%
Total Long-Term Assets	$12.64M	$10.21M
YoY Change	23.83%	39.21%
TOTAL ASSETS
Total Short-Term Assets	$24.80M	$59.24M
Total Long-Term Assets	$12.64M	$10.21M
Total Assets	$37.44M	$69.45M
YoY Change	-46.1%	3.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.224M	$3.307M
YoY Change	27.73%	5.89%
Accrued Expenses	$4.373M	$4.032M
YoY Change	8.46%	-34.55%
Deferred Revenue	$2.163M	$2.170M
YoY Change	-0.32%	-0.43%
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$6.631M
YoY Change
Total Short-Term Liabilities	$19.60M	$11.23M
YoY Change	74.46%	-15.91%
LONG-TERM LIABILITIES
Long-Term Debt	$11.78M	$21.04M
YoY Change	-44.02%	1.73%
Other Long-Term Liabilities	$14.00K	$11.00M
YoY Change	-99.87%	-0.11%
Total Long-Term Liabilities	$11.79M	$21.04M
YoY Change	-43.96%	1.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.60M	$11.23M
Total Long-Term Liabilities	$11.79M	$21.04M
Total Liabilities	$42.24M	$43.27M
YoY Change	-2.38%	-3.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$377.2M	-$345.2M
YoY Change	9.27%	9.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.807M	$26.18M
YoY Change
Total Liabilities & Shareholders Equity	$37.44M	$69.45M
YoY Change	-46.1%	3.93%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$7.162M	-$7.752M
YoY Change	-7.61%	-2.91%
Depreciation, Depletion And Amortization	$138.0K	$202.0K
YoY Change	-31.68%	-3.35%
Cash From Operating Activities	-$9.800M	-$12.50M
YoY Change	-21.57%	91.11%
INVESTING ACTIVITIES
Capital Expenditures	-$29.00K	-$38.00K
YoY Change	-23.68%	-81.0%
Acquisitions
YoY Change
Other Investing Activities	$9.162M	-$474.0K
YoY Change	-2032.91%	-116.99%
Cash From Investing Activities	$9.133M	-$512.0K
YoY Change	-1883.79%	-119.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.687M	$0.00
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-$9.800M	-$12.50M
Cash From Investing Activities	$9.133M	-$512.0K
Cash From Financing Activities	-$2.687M	$0.00
Net Change In Cash	-$3.366M	-$13.01M
YoY Change	-74.12%	-150.8%
FREE CASH FLOW
Cash From Operating Activities	-$9.800M	-$12.50M
Capital Expenditures	-$29.00K	-$38.00K
Free Cash Flow	-$9.771M	-$12.46M
YoY Change	-21.56%	96.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9914000	USD
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-23661
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3317208
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	30142 S. Wixom Road
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wixom
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48393
CY2022Q1	dei	City Area Code CityAreaCode	248
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	960-9009
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2022Q1	dei	Trading Symbol TradingSymbol	RMTI
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8532478	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9914000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13280000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9158000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7121000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5913000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	5531000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4076000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2231000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2861000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	24797000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	35288000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2377000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2486000	USD
CY2022Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	1523000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1523000	USD
CY2022Q1	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	7200000	USD
CY2021Q4	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	7737000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	921000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	921000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	618000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	619000	USD
CY2022Q1	us-gaap	Assets Assets	37436000	USD
CY2021Q4	us-gaap	Assets Assets	48574000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4224000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3739000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4373000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5090000	USD
CY2022Q1	rmti	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	1983000	USD
CY2021Q4	rmti	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	2004000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2163000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2171000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6631000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7381000	USD
CY2022Q1	us-gaap	Notes Payable NotesPayable	0	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	437000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	221000	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	144000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19595000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20966000	USD
CY2022Q1	rmti	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	5400000	USD
CY2021Q4	rmti	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	5887000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11778000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13186000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5456000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5986000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	42243000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	46039000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8544225	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8544225	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8544225	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8544225	shares
CY2022Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1000	USD
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	372383000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	372562000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-377242000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-370080000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	51000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	52000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4807000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2535000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37436000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48574000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16124000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15473000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16910000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15072000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	-786000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	401000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1567000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1809000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	455000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1851000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3818000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3923000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6626000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7182000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	540000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	581000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-536000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-570000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7162000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-179000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-236000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8544225	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8544225	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8508278	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8508278	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7162000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7163000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7756000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2535000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7162000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-179000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4807000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34170000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-236000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	26178000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7162000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	138000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	202000	USD
CY2022Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	USD
CY2021Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	71000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	520000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	412000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	92000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	92000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-6000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1208000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2426000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1455000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	424000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-630000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-317000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	485000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-848000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-490000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-410000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-640000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-958000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-538000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-544000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3216000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	5293000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9812000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12495000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2810000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7212000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11972000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6738000	USD
CY2022Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	29000	USD
CY2021Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	38000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9133000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-512000	USD
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2250000	USD
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	437000	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2687000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3366000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13007000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13280000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48682000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35675000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	461000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	485000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7000	USD
CY2022Q1	rmti	Years Of Service YearsOfService	P25Y
CY2022Q1	rmti	Entity Yearly Revenue EntityYearlyRevenue	60000000	USD
CY2022Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	300	employee
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-377200000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4800000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9900000	USD
CY2022Q1	rmti	Working Capital Net WorkingCapitalNet	5200000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9800000	USD
	rmti	Period To Regain Nasdaq Minimum Bid Requirements PeriodToRegainNasdaqMinimumBidRequirements	P180D
CY2021Q4	rmti	Common Stock Closing Bid Price CommonStockClosingBidPrice	1.00
	rmti	Number Of Consecutive Business Days NumberOfConsecutiveBusinessDays	10	businessDay
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2942517	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2989588	shares
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7600000	USD
CY2022Q1	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	5	agreement
CY2022Q1	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
CY2022Q1	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P45D
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16124000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15473000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Other Receivables OtherReceivables	7121000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	5913000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7619000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8157000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	9143000	USD
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8544225	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8544225	shares
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	14000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9158000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4312000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3434000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	408000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	201000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2334000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1964000	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8544225	shares
CY2022Q1	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	7054000	USD
CY2021Q4	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	5599000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9576000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9589000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7199000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7103000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2377000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2486000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2022Q1	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	338000	USD
CY2021Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	366000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1158000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1791000	USD
CY2022Q1	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	537000	USD
CY2021Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	796000	USD
CY2022Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	458000	USD
CY2021Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	382000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1882000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1755000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4373000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5090000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.054
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8544225	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-179000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-236000	USD
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
CY2022Q1	rmti	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	7400000	USD
CY2022Q1	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	7200000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7900000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7700000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	449000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	419000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	95000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	102000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	544000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	521000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	141000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	45000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	47000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13000	USD
CY2022Q1	rmti	Finance Lease Expense FinanceLeaseExpense	188000	USD
CY2021Q1	rmti	Finance Lease Expense FinanceLeaseExpense	58000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	736000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	583000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	464000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	425000	USD
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	47000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	13000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	118000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	37000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1896000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	460000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M12D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3489000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1307000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	495000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1456000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	669000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1114000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	672000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	637000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	676000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	260000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	666000	USD
CY2022Q1	rmti	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	121000	USD
CY2022Q1	rmti	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	311000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4895000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	485000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	516000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4410000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2973000	USD

Files In Submission

Name	View Source	Status
0001628280-22-014502-index-headers.html	Edgar Link	pending
0001628280-22-014502-index.html	Edgar Link	pending
0001628280-22-014502.txt	Edgar Link	pending
0001628280-22-014502-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmit-20220331xxamendmentto.htm	Edgar Link	pending
rmti-20220331.htm	Edgar Link	pending
rmti-20220331.xsd	Edgar Link	pending
rmti-20220331x10qex311.htm	Edgar Link	pending
rmti-20220331x10qex312.htm	Edgar Link	pending
rmti-20220331x10qex321.htm	Edgar Link	pending
rmti-20220331xxsecuritiesp.htm	Edgar Link	pending
rmti-20220331_cal.xml	Edgar Link	unprocessable
rmti-20220331_def.xml	Edgar Link	unprocessable
rmti-20220331_htm.xml	Edgar Link	completed
rmti-20220331_lab.xml	Edgar Link	unprocessable
rmti-20220331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2022 Q1 Form 10-Q Financial Statement

#000162828022014502 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2022 Q1 Form 10-Q Financial Statement

#000162828022014502 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti